Filter News
Area of Research
- (-) National Security (5)
- (-) Neutron Science (15)
- (-) Supercomputing (51)
- Biological Systems (1)
- Biology and Environment (26)
- Clean Energy (20)
- Computational Biology (1)
- Computational Engineering (1)
- Fusion and Fission (7)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (7)
- Materials (12)
- Materials for Computing (3)
- Nuclear Science and Technology (11)
News Type
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (18)
- (-) Coronavirus (16)
- (-) Exascale Computing (19)
- (-) Frontier (26)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (12)
- Artificial Intelligence (44)
- Big Data (17)
- Bioenergy (14)
- Biology (15)
- Biotechnology (3)
- Buildings (3)
- Chemical Sciences (4)
- Clean Water (2)
- Climate Change (18)
- Composites (1)
- Computer Science (87)
- Cybersecurity (21)
- Decarbonization (7)
- Energy Storage (10)
- Environment (25)
- Fossil Energy (1)
- Fusion (2)
- Grid (8)
- High-Performance Computing (34)
- Isotopes (1)
- Machine Learning (23)
- Materials (23)
- Materials Science (28)
- Mathematics (1)
- Microscopy (7)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (34)
- Net Zero (1)
- Neutron Science (75)
- Nuclear Energy (7)
- Partnerships (4)
- Physics (16)
- Polymers (1)
- Quantum Computing (15)
- Quantum Science (24)
- Security (13)
- Simulation (11)
- Software (1)
- Summit (35)
- Sustainable Energy (9)
- Transportation (8)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.